Capture and harvest of Circulating Tumor Cells from blood* ANGLE’s ParsortixTM


technology captures circulating tumor cells (CTCs) from blood* . The


resulting “liquid biopsy” enables the genetic and protein analysis of the patient’s cancer which has the potential to help direct optimal therapy – so moving towards personalised cancer care.


Capture and harvest of CTCs from a wide range of cancers including lung, breast, prostate, colo-rectal, ovarian


Antibody independent capture – including capture of mesenchymal cells and clusters of cells


Simple operation with minimal user intervention


Delivers viable cells ready for molecular and functional analysis


Workflow allows the analysis of ctDNA and CTCs from the same patient sample


*Research use only – not for use in diagnostic procedures


For more information and latest publications please visit www.angleplc.com or email parsortix@angleplc.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14